Communication design for biotech startup
Driving Business Growth Through DesignTessera Therapeutics
Role
Partnered with Edelman PR for a $300M Series C biotech company to to unify brand communication across stakeholders.
Challenge
Translate complex biotech innovation into a clear, credible visual language for investors, media, and employees while enabling scalable, consistent brand execution.
Strategic Approach
Partnered with PR firm to turn communications strategy into scalable visual systems
Built flexible templates and adaptable framework supporting diverse communication needs while maintaining essential brand standards and consistency
Balanced scientific credibility with innovation through biotech-specific design direction
Design Execution
Created social and digital templates for investor news, milestones, and media outreach
Designed cohesive internal collateral reinforcing brand presence
Developed visual guidelines and governance enabling cross-team adoption
Business Impact
Established reusable visual foundation supporting ongoing communication needs through multiple growth stages
Boosted internal alignment and reduced production time through templatized, scalable system
Strengthened brand credibility and visibility across biotech and investor audiences
Client Tessera Therapeutics in collaboration with Edelman
Flagship Pioneering company, Funded $300M Series C from Softbank Vision Fund, Qatar Investment Authority, Flagship Pioneering etc.
Disciplines Brand Systems | Communications Design
